News Column

CELLECTAR BIOSCIENCES, INC. FILES (8-K) Disclosing Regulation FD Disclosure, Financial Statements and Exhibits

August 26, 2014



ITEM 7.01 REGULATION FD DISCLOSURE

On August 20, 2014, we issued a press release announcing that we had closed our underwritten public offering of 3,333,333 shares of common stock at a per share price of $3.75 and warrants to purchase up to the same number of shares of common stock at a per warrant price of $0.01; plus the issuance of approximately an additional 1,110,000 shares and warrants in consideration of the cancellation of $4,000,000 principal amount of convertible debentures plus accrued interest. The press released also announced that the underwriter partially exercised the over-allotment option to purchase an additional 250,000 shares of common stock and acquired warrants to purchase 500,000 shares of common stock. A copy of the press release is furnished as Exhibit 99.1 and is incorporated by reference herein.

Also on August 20, 2014, we issued a press release announcing recent company highlights and our results for the second quarter and six months ended June 30, 2014.A copy of the press release is furnished as Exhibit 99.2 and is incorporated by reference herein.

2



ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits Number Title 99.1 Press release dated August 20, 2014, entitled "Cellectar Biosciences Announces Closing of Public Offering and Partial Exercise of Underwriter's Over-Allotment Option" 99.2 Press release dated August 20, 2014, entitled "Cellectar Biosciences Reports Second Quarter 2014 Financial Results and Recent Highlights" 3


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters